Skip to main content
. 2021 Sep 17;22(18):10027. doi: 10.3390/ijms221810027

Figure 6.

Figure 6

Anticancer effects of a combination treatment with metformin and DCA in a mouse model bearing MH-134 cells. (A) Tumor volume in the combination treatment group at 13–15 days was significantly smaller than that in the control or metformin treatment groups (all, p < 0.05). (B) In the combination treatment group, tumor tissues showed TUNEL-positive staining (400× magnification). * p < 0.05.